nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—HTR3A—Memantine—Alzheimer's disease	0.277	0.548	CbGbCtD
Metoclopramide—CYP2D6—Alzheimer's disease	0.229	1	CbGaD
Metoclopramide—DRD2—Memantine—Alzheimer's disease	0.104	0.205	CbGbCtD
Metoclopramide—CYP2D6—Rivastigmine—Alzheimer's disease	0.054	0.107	CbGbCtD
Metoclopramide—CYP2D6—Donepezil—Alzheimer's disease	0.0432	0.0853	CbGbCtD
Metoclopramide—CYP2D6—Galantamine—Alzheimer's disease	0.0278	0.055	CbGbCtD
Metoclopramide—DRD3—telencephalic ventricle—Alzheimer's disease	0.00756	0.208	CbGeAlD
Metoclopramide—Cogwheel rigidity—Rivastigmine—Alzheimer's disease	0.00503	0.0366	CcSEcCtD
Metoclopramide—Bradykinesia—Rivastigmine—Alzheimer's disease	0.00479	0.0348	CcSEcCtD
Metoclopramide—HTR4—telencephalon—Alzheimer's disease	0.00465	0.128	CbGeAlD
Metoclopramide—Incontinence—Galantamine—Alzheimer's disease	0.00382	0.0278	CcSEcCtD
Metoclopramide—DRD2—telencephalic ventricle—Alzheimer's disease	0.0032	0.0879	CbGeAlD
Metoclopramide—Suicide—Galantamine—Alzheimer's disease	0.00257	0.0187	CcSEcCtD
Metoclopramide—Tardive dyskinesia—Memantine—Alzheimer's disease	0.00252	0.0183	CcSEcCtD
Metoclopramide—Hyperpyrexia—Rivastigmine—Alzheimer's disease	0.00247	0.0179	CcSEcCtD
Metoclopramide—Dysphoria—Donepezil—Alzheimer's disease	0.00239	0.0174	CcSEcCtD
Metoclopramide—Completed suicide—Galantamine—Alzheimer's disease	0.00227	0.0165	CcSEcCtD
Metoclopramide—HTR4—brain—Alzheimer's disease	0.0021	0.0576	CbGeAlD
Metoclopramide—Supraventricular tachycardia—Galantamine—Alzheimer's disease	0.00204	0.0148	CcSEcCtD
Metoclopramide—Altered state of consciousness—Memantine—Alzheimer's disease	0.00203	0.0148	CcSEcCtD
Metoclopramide—Neuroleptic malignant syndrome—Donepezil—Alzheimer's disease	0.00202	0.0147	CcSEcCtD
Metoclopramide—Suicidal ideation—Galantamine—Alzheimer's disease	0.0019	0.0138	CcSEcCtD
Metoclopramide—Neuroleptic malignant syndrome—Memantine—Alzheimer's disease	0.00183	0.0133	CcSEcCtD
Metoclopramide—Block heart—Donepezil—Alzheimer's disease	0.00182	0.0133	CcSEcCtD
Metoclopramide—Suicide—Memantine—Alzheimer's disease	0.00181	0.0132	CcSEcCtD
Metoclopramide—Muscle rigidity—Rivastigmine—Alzheimer's disease	0.00179	0.0131	CcSEcCtD
Metoclopramide—Block heart—Memantine—Alzheimer's disease	0.00165	0.012	CcSEcCtD
Metoclopramide—Completed suicide—Memantine—Alzheimer's disease	0.0016	0.0116	CcSEcCtD
Metoclopramide—Supraventricular tachycardia—Donepezil—Alzheimer's disease	0.00158	0.0115	CcSEcCtD
Metoclopramide—Delirium—Galantamine—Alzheimer's disease	0.00155	0.0113	CcSEcCtD
Metoclopramide—Supraventricular tachycardia—Memantine—Alzheimer's disease	0.00143	0.0104	CcSEcCtD
Metoclopramide—Supraventricular tachycardia—Rivastigmine—Alzheimer's disease	0.0014	0.0102	CcSEcCtD
Metoclopramide—Atrioventricular block—Galantamine—Alzheimer's disease	0.00138	0.01	CcSEcCtD
Metoclopramide—Extrapyramidal disorder—Donepezil—Alzheimer's disease	0.00137	0.00999	CcSEcCtD
Metoclopramide—HTR3A—forebrain—Alzheimer's disease	0.00137	0.0375	CbGeAlD
Metoclopramide—Suicidal ideation—Memantine—Alzheimer's disease	0.00134	0.00974	CcSEcCtD
Metoclopramide—Ventricular tachycardia—Galantamine—Alzheimer's disease	0.00133	0.0097	CcSEcCtD
Metoclopramide—Suicidal ideation—Rivastigmine—Alzheimer's disease	0.00131	0.00953	CcSEcCtD
Metoclopramide—Mania—Memantine—Alzheimer's disease	0.00129	0.00939	CcSEcCtD
Metoclopramide—Urinary incontinence—Galantamine—Alzheimer's disease	0.00129	0.00937	CcSEcCtD
Metoclopramide—HTR3A—telencephalon—Alzheimer's disease	0.00126	0.0345	CbGeAlD
Metoclopramide—Extrapyramidal disorder—Memantine—Alzheimer's disease	0.00125	0.00907	CcSEcCtD
Metoclopramide—Extrapyramidal disorder—Rivastigmine—Alzheimer's disease	0.00122	0.00887	CcSEcCtD
Metoclopramide—Delirium—Memantine—Alzheimer's disease	0.00109	0.00794	CcSEcCtD
Metoclopramide—DRD3—nervous system—Alzheimer's disease	0.00107	0.0294	CbGeAlD
Metoclopramide—Delirium—Rivastigmine—Alzheimer's disease	0.00107	0.00777	CcSEcCtD
Metoclopramide—Atrioventricular block—Donepezil—Alzheimer's disease	0.00107	0.00775	CcSEcCtD
Metoclopramide—CHRM1—forebrain—Alzheimer's disease	0.00104	0.0285	CbGeAlD
Metoclopramide—DRD3—central nervous system—Alzheimer's disease	0.00103	0.0283	CbGeAlD
Metoclopramide—Atrial fibrillation—Galantamine—Alzheimer's disease	0.00102	0.00743	CcSEcCtD
Metoclopramide—Renal impairment—Galantamine—Alzheimer's disease	0.00102	0.0074	CcSEcCtD
Metoclopramide—Wheezing—Donepezil—Alzheimer's disease	0.001	0.0073	CcSEcCtD
Metoclopramide—Dyskinesia—Memantine—Alzheimer's disease	0.000999	0.00727	CcSEcCtD
Metoclopramide—Urinary incontinence—Donepezil—Alzheimer's disease	0.000998	0.00726	CcSEcCtD
Metoclopramide—Dyskinesia—Rivastigmine—Alzheimer's disease	0.000977	0.00711	CcSEcCtD
Metoclopramide—Atrioventricular block—Memantine—Alzheimer's disease	0.000968	0.00704	CcSEcCtD
Metoclopramide—Respiratory failure—Memantine—Alzheimer's disease	0.000956	0.00695	CcSEcCtD
Metoclopramide—CHRM1—telencephalon—Alzheimer's disease	0.000954	0.0262	CbGeAlD
Metoclopramide—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.000947	0.00689	CcSEcCtD
Metoclopramide—CYP17A1—nervous system—Alzheimer's disease	0.000945	0.026	CbGeAlD
Metoclopramide—Respiratory failure—Rivastigmine—Alzheimer's disease	0.000935	0.0068	CcSEcCtD
Metoclopramide—CYP17A1—central nervous system—Alzheimer's disease	0.00091	0.025	CbGeAlD
Metoclopramide—Urinary incontinence—Memantine—Alzheimer's disease	0.000906	0.00659	CcSEcCtD
Metoclopramide—Urinary incontinence—Rivastigmine—Alzheimer's disease	0.000887	0.00645	CcSEcCtD
Metoclopramide—Fluid retention—Rivastigmine—Alzheimer's disease	0.000872	0.00634	CcSEcCtD
Metoclopramide—Cinchocaine—CALM1—Alzheimer's disease	0.000839	0.158	CrCbGaD
Metoclopramide—DRD2—forebrain—Alzheimer's disease	0.000835	0.0229	CbGeAlD
Metoclopramide—Rash maculo-papular—Rivastigmine—Alzheimer's disease	0.000835	0.00607	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.000828	0.00602	CcSEcCtD
Metoclopramide—DRD3—brain—Alzheimer's disease	0.000819	0.0225	CbGeAlD
Metoclopramide—Sunitinib—PTK2B—Alzheimer's disease	0.000793	0.149	CrCbGaD
Metoclopramide—Sunitinib—LRRK2—Alzheimer's disease	0.000793	0.149	CrCbGaD
Metoclopramide—Atrial fibrillation—Donepezil—Alzheimer's disease	0.000792	0.00576	CcSEcCtD
Metoclopramide—Pollakiuria—Galantamine—Alzheimer's disease	0.000773	0.00562	CcSEcCtD
Metoclopramide—DRD2—telencephalon—Alzheimer's disease	0.000768	0.0211	CbGeAlD
Metoclopramide—Cardiac failure congestive—Memantine—Alzheimer's disease	0.000751	0.00547	CcSEcCtD
Metoclopramide—Depression—Galantamine—Alzheimer's disease	0.000744	0.00541	CcSEcCtD
Metoclopramide—HTR3A—nervous system—Alzheimer's disease	0.000741	0.0204	CbGeAlD
Metoclopramide—CYP17A1—brain—Alzheimer's disease	0.000722	0.0198	CbGeAlD
Metoclopramide—Atrial fibrillation—Memantine—Alzheimer's disease	0.000719	0.00523	CcSEcCtD
Metoclopramide—Renal impairment—Memantine—Alzheimer's disease	0.000716	0.00521	CcSEcCtD
Metoclopramide—HTR3A—central nervous system—Alzheimer's disease	0.000714	0.0196	CbGeAlD
Metoclopramide—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.000703	0.00512	CcSEcCtD
Metoclopramide—Renal impairment—Rivastigmine—Alzheimer's disease	0.0007	0.00509	CcSEcCtD
Metoclopramide—Bradycardia—Galantamine—Alzheimer's disease	0.000682	0.00496	CcSEcCtD
Metoclopramide—Hallucination—Galantamine—Alzheimer's disease	0.000667	0.00485	CcSEcCtD
Metoclopramide—Asthma—Donepezil—Alzheimer's disease	0.000649	0.00472	CcSEcCtD
Metoclopramide—Cardiac arrest—Memantine—Alzheimer's disease	0.000648	0.00471	CcSEcCtD
Metoclopramide—Visual impairment—Galantamine—Alzheimer's disease	0.000646	0.0047	CcSEcCtD
Metoclopramide—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.000634	0.00461	CcSEcCtD
Metoclopramide—Flushing—Galantamine—Alzheimer's disease	0.000622	0.00452	CcSEcCtD
Metoclopramide—Pollakiuria—Donepezil—Alzheimer's disease	0.000599	0.00436	CcSEcCtD
Metoclopramide—Asthma—Memantine—Alzheimer's disease	0.000589	0.00428	CcSEcCtD
Metoclopramide—Bronchospasm—Memantine—Alzheimer's disease	0.000579	0.00421	CcSEcCtD
Metoclopramide—Depression—Donepezil—Alzheimer's disease	0.000577	0.00419	CcSEcCtD
Metoclopramide—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000567	0.00412	CcSEcCtD
Metoclopramide—HTR3A—brain—Alzheimer's disease	0.000567	0.0156	CbGeAlD
Metoclopramide—Nervousness—Galantamine—Alzheimer's disease	0.000566	0.00412	CcSEcCtD
Metoclopramide—Jaundice—Donepezil—Alzheimer's disease	0.000564	0.0041	CcSEcCtD
Metoclopramide—CHRM1—nervous system—Alzheimer's disease	0.000563	0.0155	CbGeAlD
Metoclopramide—Muscle spasms—Galantamine—Alzheimer's disease	0.000561	0.00408	CcSEcCtD
Metoclopramide—Neutropenia—Memantine—Alzheimer's disease	0.000551	0.00401	CcSEcCtD
Metoclopramide—Tremor—Galantamine—Alzheimer's disease	0.000546	0.00397	CcSEcCtD
Metoclopramide—Pollakiuria—Memantine—Alzheimer's disease	0.000544	0.00396	CcSEcCtD
Metoclopramide—Erectile dysfunction—Memantine—Alzheimer's disease	0.000542	0.00395	CcSEcCtD
Metoclopramide—CHRM1—central nervous system—Alzheimer's disease	0.000542	0.0149	CbGeAlD
Metoclopramide—Agitation—Galantamine—Alzheimer's disease	0.000536	0.0039	CcSEcCtD
Metoclopramide—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000532	0.00387	CcSEcCtD
Metoclopramide—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000531	0.00386	CcSEcCtD
Metoclopramide—Bradycardia—Donepezil—Alzheimer's disease	0.000529	0.00384	CcSEcCtD
Metoclopramide—Depression—Memantine—Alzheimer's disease	0.000524	0.00381	CcSEcCtD
Metoclopramide—Hallucination—Donepezil—Alzheimer's disease	0.000517	0.00376	CcSEcCtD
Metoclopramide—Palpitations—Galantamine—Alzheimer's disease	0.000515	0.00375	CcSEcCtD
Metoclopramide—Drowsiness—Rivastigmine—Alzheimer's disease	0.000514	0.00374	CcSEcCtD
Metoclopramide—Depression—Rivastigmine—Alzheimer's disease	0.000512	0.00373	CcSEcCtD
Metoclopramide—Convulsion—Galantamine—Alzheimer's disease	0.000505	0.00368	CcSEcCtD
Metoclopramide—Hypertension—Galantamine—Alzheimer's disease	0.000504	0.00366	CcSEcCtD
Metoclopramide—CYP2D6—forebrain—Alzheimer's disease	0.000502	0.0138	CbGeAlD
Metoclopramide—Visual impairment—Donepezil—Alzheimer's disease	0.0005	0.00364	CcSEcCtD
Metoclopramide—Anxiety—Galantamine—Alzheimer's disease	0.000495	0.0036	CcSEcCtD
Metoclopramide—Agranulocytosis—Memantine—Alzheimer's disease	0.00049	0.00356	CcSEcCtD
Metoclopramide—Confusional state—Galantamine—Alzheimer's disease	0.00048	0.00349	CcSEcCtD
Metoclopramide—Bradycardia—Memantine—Alzheimer's disease	0.00048	0.00349	CcSEcCtD
Metoclopramide—Bradycardia—Rivastigmine—Alzheimer's disease	0.000469	0.00341	CcSEcCtD
Metoclopramide—Hallucination—Memantine—Alzheimer's disease	0.000469	0.00341	CcSEcCtD
Metoclopramide—Tachycardia—Galantamine—Alzheimer's disease	0.000465	0.00338	CcSEcCtD
Metoclopramide—CYP2D6—telencephalon—Alzheimer's disease	0.000462	0.0127	CbGeAlD
Metoclopramide—Hallucination—Rivastigmine—Alzheimer's disease	0.000459	0.00334	CcSEcCtD
Metoclopramide—Visual impairment—Memantine—Alzheimer's disease	0.000454	0.0033	CcSEcCtD
Metoclopramide—DRD2—nervous system—Alzheimer's disease	0.000453	0.0125	CbGeAlD
Metoclopramide—Hypotension—Galantamine—Alzheimer's disease	0.000445	0.00323	CcSEcCtD
Metoclopramide—Visual impairment—Rivastigmine—Alzheimer's disease	0.000444	0.00323	CcSEcCtD
Metoclopramide—Nervousness—Donepezil—Alzheimer's disease	0.000439	0.00319	CcSEcCtD
Metoclopramide—Flushing—Memantine—Alzheimer's disease	0.000438	0.00318	CcSEcCtD
Metoclopramide—DRD2—central nervous system—Alzheimer's disease	0.000437	0.012	CbGeAlD
Metoclopramide—Muscle spasms—Donepezil—Alzheimer's disease	0.000435	0.00316	CcSEcCtD
Metoclopramide—Insomnia—Galantamine—Alzheimer's disease	0.00043	0.00313	CcSEcCtD
Metoclopramide—CHRM1—brain—Alzheimer's disease	0.00043	0.0118	CbGeAlD
Metoclopramide—Flushing—Rivastigmine—Alzheimer's disease	0.000428	0.00311	CcSEcCtD
Metoclopramide—DRD2—cerebellum—Alzheimer's disease	0.000427	0.0117	CbGeAlD
Metoclopramide—Tremor—Donepezil—Alzheimer's disease	0.000423	0.00308	CcSEcCtD
Metoclopramide—Somnolence—Galantamine—Alzheimer's disease	0.000423	0.00308	CcSEcCtD
Metoclopramide—Oxybuprocaine—BCHE—Alzheimer's disease	0.000418	0.0788	CrCbGaD
Metoclopramide—Agitation—Donepezil—Alzheimer's disease	0.000415	0.00302	CcSEcCtD
Metoclopramide—Fatigue—Galantamine—Alzheimer's disease	0.00041	0.00298	CcSEcCtD
Metoclopramide—Nervousness—Memantine—Alzheimer's disease	0.000399	0.0029	CcSEcCtD
Metoclopramide—Feeling abnormal—Galantamine—Alzheimer's disease	0.000392	0.00285	CcSEcCtD
Metoclopramide—Convulsion—Donepezil—Alzheimer's disease	0.000392	0.00285	CcSEcCtD
Metoclopramide—Hypertension—Donepezil—Alzheimer's disease	0.00039	0.00284	CcSEcCtD
Metoclopramide—Nervousness—Rivastigmine—Alzheimer's disease	0.00039	0.00284	CcSEcCtD
Metoclopramide—Chloroprocaine—BCHE—Alzheimer's disease	0.000389	0.0732	CrCbGaD
Metoclopramide—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000386	0.00281	CcSEcCtD
Metoclopramide—Tremor—Memantine—Alzheimer's disease	0.000384	0.0028	CcSEcCtD
Metoclopramide—Anxiety—Donepezil—Alzheimer's disease	0.000383	0.00279	CcSEcCtD
Metoclopramide—Agitation—Memantine—Alzheimer's disease	0.000377	0.00274	CcSEcCtD
Metoclopramide—Body temperature increased—Galantamine—Alzheimer's disease	0.000376	0.00274	CcSEcCtD
Metoclopramide—Tremor—Rivastigmine—Alzheimer's disease	0.000376	0.00274	CcSEcCtD
Metoclopramide—Confusional state—Donepezil—Alzheimer's disease	0.000372	0.00271	CcSEcCtD
Metoclopramide—Cinchocaine—BCHE—Alzheimer's disease	0.000371	0.0699	CrCbGaD
Metoclopramide—Procaine—BCHE—Alzheimer's disease	0.000371	0.0699	CrCbGaD
Metoclopramide—Agitation—Rivastigmine—Alzheimer's disease	0.000369	0.00268	CcSEcCtD
Metoclopramide—Oedema—Donepezil—Alzheimer's disease	0.000369	0.00268	CcSEcCtD
Metoclopramide—Leukopenia—Memantine—Alzheimer's disease	0.000367	0.00267	CcSEcCtD
Metoclopramide—Palpitations—Memantine—Alzheimer's disease	0.000363	0.00264	CcSEcCtD
Metoclopramide—Convulsion—Memantine—Alzheimer's disease	0.000356	0.00259	CcSEcCtD
Metoclopramide—Palpitations—Rivastigmine—Alzheimer's disease	0.000355	0.00258	CcSEcCtD
Metoclopramide—Hypertension—Memantine—Alzheimer's disease	0.000354	0.00258	CcSEcCtD
Metoclopramide—Hypersensitivity—Galantamine—Alzheimer's disease	0.000351	0.00255	CcSEcCtD
Metoclopramide—Anxiety—Memantine—Alzheimer's disease	0.000348	0.00253	CcSEcCtD
Metoclopramide—Convulsion—Rivastigmine—Alzheimer's disease	0.000348	0.00253	CcSEcCtD
Metoclopramide—DRD2—brain—Alzheimer's disease	0.000347	0.00952	CbGeAlD
Metoclopramide—Hypertension—Rivastigmine—Alzheimer's disease	0.000347	0.00252	CcSEcCtD
Metoclopramide—Hypotension—Donepezil—Alzheimer's disease	0.000345	0.00251	CcSEcCtD
Metoclopramide—Asthenia—Galantamine—Alzheimer's disease	0.000341	0.00248	CcSEcCtD
Metoclopramide—Anxiety—Rivastigmine—Alzheimer's disease	0.000341	0.00248	CcSEcCtD
Metoclopramide—Confusional state—Memantine—Alzheimer's disease	0.000338	0.00246	CcSEcCtD
Metoclopramide—Oedema—Memantine—Alzheimer's disease	0.000335	0.00244	CcSEcCtD
Metoclopramide—Insomnia—Donepezil—Alzheimer's disease	0.000334	0.00243	CcSEcCtD
Metoclopramide—Amisulpride—HTR2A—Alzheimer's disease	0.000331	0.0624	CrCbGaD
Metoclopramide—Confusional state—Rivastigmine—Alzheimer's disease	0.00033	0.0024	CcSEcCtD
Metoclopramide—Dyspnoea—Donepezil—Alzheimer's disease	0.000329	0.00239	CcSEcCtD
Metoclopramide—Somnolence—Donepezil—Alzheimer's disease	0.000328	0.00239	CcSEcCtD
Metoclopramide—Oedema—Rivastigmine—Alzheimer's disease	0.000328	0.00238	CcSEcCtD
Metoclopramide—Tachycardia—Memantine—Alzheimer's disease	0.000327	0.00238	CcSEcCtD
Metoclopramide—Procainamide—ACHE—Alzheimer's disease	0.000326	0.0615	CrCbGaD
Metoclopramide—Diarrhoea—Galantamine—Alzheimer's disease	0.000326	0.00237	CcSEcCtD
Metoclopramide—Tachycardia—Rivastigmine—Alzheimer's disease	0.00032	0.00233	CcSEcCtD
Metoclopramide—Fatigue—Donepezil—Alzheimer's disease	0.000318	0.00231	CcSEcCtD
Metoclopramide—Dizziness—Galantamine—Alzheimer's disease	0.000315	0.00229	CcSEcCtD
Metoclopramide—Hypotension—Memantine—Alzheimer's disease	0.000313	0.00228	CcSEcCtD
Metoclopramide—Hypotension—Rivastigmine—Alzheimer's disease	0.000306	0.00223	CcSEcCtD
Metoclopramide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000304	0.00221	CcSEcCtD
Metoclopramide—Insomnia—Memantine—Alzheimer's disease	0.000303	0.0022	CcSEcCtD
Metoclopramide—Rash—Galantamine—Alzheimer's disease	0.0003	0.00218	CcSEcCtD
Metoclopramide—Dermatitis—Galantamine—Alzheimer's disease	0.0003	0.00218	CcSEcCtD
Metoclopramide—Dyspnoea—Memantine—Alzheimer's disease	0.000299	0.00217	CcSEcCtD
Metoclopramide—Headache—Galantamine—Alzheimer's disease	0.000298	0.00217	CcSEcCtD
Metoclopramide—Somnolence—Memantine—Alzheimer's disease	0.000298	0.00217	CcSEcCtD
Metoclopramide—Insomnia—Rivastigmine—Alzheimer's disease	0.000296	0.00216	CcSEcCtD
Metoclopramide—Urticaria—Donepezil—Alzheimer's disease	0.000293	0.00213	CcSEcCtD
Metoclopramide—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000292	0.00212	CcSEcCtD
Metoclopramide—Body temperature increased—Donepezil—Alzheimer's disease	0.000292	0.00212	CcSEcCtD
Metoclopramide—Somnolence—Rivastigmine—Alzheimer's disease	0.000291	0.00212	CcSEcCtD
Metoclopramide—Fatigue—Memantine—Alzheimer's disease	0.000289	0.0021	CcSEcCtD
Metoclopramide—Nausea—Galantamine—Alzheimer's disease	0.000283	0.00206	CcSEcCtD
Metoclopramide—Fatigue—Rivastigmine—Alzheimer's disease	0.000282	0.00205	CcSEcCtD
Metoclopramide—Feeling abnormal—Memantine—Alzheimer's disease	0.000276	0.00201	CcSEcCtD
Metoclopramide—CYP2D6—nervous system—Alzheimer's disease	0.000272	0.00748	CbGeAlD
Metoclopramide—Hypersensitivity—Donepezil—Alzheimer's disease	0.000272	0.00198	CcSEcCtD
Metoclopramide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00027	0.00196	CcSEcCtD
Metoclopramide—Urticaria—Memantine—Alzheimer's disease	0.000266	0.00194	CcSEcCtD
Metoclopramide—Body temperature increased—Memantine—Alzheimer's disease	0.000265	0.00193	CcSEcCtD
Metoclopramide—Asthenia—Donepezil—Alzheimer's disease	0.000265	0.00192	CcSEcCtD
Metoclopramide—CYP2D6—central nervous system—Alzheimer's disease	0.000262	0.00721	CbGeAlD
Metoclopramide—Urticaria—Rivastigmine—Alzheimer's disease	0.00026	0.00189	CcSEcCtD
Metoclopramide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000259	0.00188	CcSEcCtD
Metoclopramide—CYP2D6—cerebellum—Alzheimer's disease	0.000256	0.00704	CbGeAlD
Metoclopramide—Diarrhoea—Donepezil—Alzheimer's disease	0.000252	0.00184	CcSEcCtD
Metoclopramide—Hypersensitivity—Memantine—Alzheimer's disease	0.000247	0.00179	CcSEcCtD
Metoclopramide—Dizziness—Donepezil—Alzheimer's disease	0.000244	0.00177	CcSEcCtD
Metoclopramide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000241	0.00176	CcSEcCtD
Metoclopramide—Asthenia—Memantine—Alzheimer's disease	0.00024	0.00175	CcSEcCtD
Metoclopramide—Asthenia—Rivastigmine—Alzheimer's disease	0.000235	0.00171	CcSEcCtD
Metoclopramide—Rash—Donepezil—Alzheimer's disease	0.000233	0.00169	CcSEcCtD
Metoclopramide—Dermatitis—Donepezil—Alzheimer's disease	0.000232	0.00169	CcSEcCtD
Metoclopramide—Headache—Donepezil—Alzheimer's disease	0.000231	0.00168	CcSEcCtD
Metoclopramide—Diarrhoea—Memantine—Alzheimer's disease	0.000229	0.00167	CcSEcCtD
Metoclopramide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000224	0.00163	CcSEcCtD
Metoclopramide—Dizziness—Memantine—Alzheimer's disease	0.000221	0.00161	CcSEcCtD
Metoclopramide—Nausea—Donepezil—Alzheimer's disease	0.000219	0.00159	CcSEcCtD
Metoclopramide—Dizziness—Rivastigmine—Alzheimer's disease	0.000217	0.00158	CcSEcCtD
Metoclopramide—Rash—Memantine—Alzheimer's disease	0.000211	0.00154	CcSEcCtD
Metoclopramide—Dermatitis—Memantine—Alzheimer's disease	0.000211	0.00153	CcSEcCtD
Metoclopramide—Headache—Memantine—Alzheimer's disease	0.00021	0.00153	CcSEcCtD
Metoclopramide—CYP2D6—brain—Alzheimer's disease	0.000208	0.00572	CbGeAlD
Metoclopramide—Rash—Rivastigmine—Alzheimer's disease	0.000207	0.0015	CcSEcCtD
Metoclopramide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000206	0.0015	CcSEcCtD
Metoclopramide—Headache—Rivastigmine—Alzheimer's disease	0.000205	0.00149	CcSEcCtD
Metoclopramide—Nausea—Memantine—Alzheimer's disease	0.000199	0.00145	CcSEcCtD
Metoclopramide—Cisapride—HTR2A—Alzheimer's disease	0.000198	0.0374	CrCbGaD
Metoclopramide—Nausea—Rivastigmine—Alzheimer's disease	0.000195	0.00142	CcSEcCtD
Metoclopramide—Procainamide—BCHE—Alzheimer's disease	0.000192	0.0362	CrCbGaD
Metoclopramide—Cisapride—CYP2D6—Alzheimer's disease	0.000181	0.0342	CrCbGaD
Metoclopramide—Procainamide—CYP2D6—Alzheimer's disease	0.000105	0.0198	CrCbGaD
Metoclopramide—CYP11B1—Metabolism—APOE—Alzheimer's disease	1.65e-05	0.000192	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—APP—Alzheimer's disease	1.64e-05	0.000192	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—INS—Alzheimer's disease	1.63e-05	0.000191	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CAV1—Alzheimer's disease	1.63e-05	0.000191	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PSENEN—Alzheimer's disease	1.62e-05	0.00019	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CCL2—Alzheimer's disease	1.62e-05	0.000189	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APH1A—Alzheimer's disease	1.6e-05	0.000187	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NOS3—Alzheimer's disease	1.6e-05	0.000187	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CCR5—Alzheimer's disease	1.6e-05	0.000187	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.59e-05	0.000186	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PSENEN—Alzheimer's disease	1.59e-05	0.000186	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PLCB1—Alzheimer's disease	1.58e-05	0.000185	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APH1A—Alzheimer's disease	1.57e-05	0.000183	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.56e-05	0.000183	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NCSTN—Alzheimer's disease	1.56e-05	0.000182	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PLCB1—Alzheimer's disease	1.55e-05	0.000181	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CALM1—Alzheimer's disease	1.55e-05	0.000181	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—APOE—Alzheimer's disease	1.54e-05	0.00018	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PRKCG—Alzheimer's disease	1.53e-05	0.000179	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NCSTN—Alzheimer's disease	1.53e-05	0.000178	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CAV1—Alzheimer's disease	1.53e-05	0.000178	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NPY—Alzheimer's disease	1.52e-05	0.000178	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—LRP1—Alzheimer's disease	1.52e-05	0.000178	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IAPP—Alzheimer's disease	1.52e-05	0.000177	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—TP53—Alzheimer's disease	1.5e-05	0.000176	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—LRP1—Alzheimer's disease	1.49e-05	0.000174	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GFAP—Alzheimer's disease	1.49e-05	0.000174	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GAL—Alzheimer's disease	1.49e-05	0.000174	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CRH—Alzheimer's disease	1.47e-05	0.000172	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—TP53—Alzheimer's disease	1.47e-05	0.000172	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GAL—Alzheimer's disease	1.45e-05	0.00017	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GFAP—Alzheimer's disease	1.45e-05	0.00017	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCR5—Alzheimer's disease	1.45e-05	0.00017	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PPARG—Alzheimer's disease	1.43e-05	0.000168	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—NOS3—Alzheimer's disease	1.43e-05	0.000167	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR2A—Alzheimer's disease	1.42e-05	0.000166	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—INS—Alzheimer's disease	1.41e-05	0.000164	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NPS—Alzheimer's disease	1.39e-05	0.000163	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PPP3CA—Alzheimer's disease	1.39e-05	0.000162	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—IL6—Alzheimer's disease	1.38e-05	0.000161	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—F2—Alzheimer's disease	1.37e-05	0.00016	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—AKT1—Alzheimer's disease	1.37e-05	0.00016	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PTK2B—Alzheimer's disease	1.37e-05	0.00016	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CASP3—Alzheimer's disease	1.36e-05	0.000159	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—IL6—Alzheimer's disease	1.35e-05	0.000158	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—IL6—Alzheimer's disease	1.35e-05	0.000157	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PPARG—Alzheimer's disease	1.34e-05	0.000157	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NTRK2—Alzheimer's disease	1.33e-05	0.000156	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GAB2—Alzheimer's disease	1.33e-05	0.000156	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SST—Alzheimer's disease	1.33e-05	0.000156	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CALM1—Alzheimer's disease	1.32e-05	0.000155	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GSK3A—Alzheimer's disease	1.32e-05	0.000154	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—INS—Alzheimer's disease	1.32e-05	0.000154	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—A2M—Alzheimer's disease	1.31e-05	0.000153	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PTGS2—Alzheimer's disease	1.31e-05	0.000153	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—APP—Alzheimer's disease	1.3e-05	0.000152	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.29e-05	0.000151	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—A2M—Alzheimer's disease	1.28e-05	0.00015	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.28e-05	0.000149	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PSEN2—Alzheimer's disease	1.27e-05	0.000148	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.26e-05	0.000148	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MAPK8—Alzheimer's disease	1.25e-05	0.000146	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—AKT1—Alzheimer's disease	1.25e-05	0.000146	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—F2—Alzheimer's disease	1.25e-05	0.000146	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PSEN2—Alzheimer's disease	1.24e-05	0.000145	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—NOS3—Alzheimer's disease	1.23e-05	0.000144	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PLCB1—Alzheimer's disease	1.22e-05	0.000143	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.22e-05	0.000143	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.2e-05	0.00014	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.2e-05	0.00014	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.17e-05	0.000137	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.17e-05	0.000137	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NPY—Alzheimer's disease	1.17e-05	0.000136	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IAPP—Alzheimer's disease	1.16e-05	0.000136	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—NOS3—Alzheimer's disease	1.15e-05	0.000135	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—VEGFA—Alzheimer's disease	1.15e-05	0.000135	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.15e-05	0.000134	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NPY—Alzheimer's disease	1.14e-05	0.000133	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NGFR—Alzheimer's disease	1.14e-05	0.000133	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IAPP—Alzheimer's disease	1.13e-05	0.000133	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CREB1—Alzheimer's disease	1.13e-05	0.000133	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PTGS2—Alzheimer's disease	1.13e-05	0.000132	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CRH—Alzheimer's disease	1.13e-05	0.000132	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ADAM10—Alzheimer's disease	1.11e-05	0.00013	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCR5—Alzheimer's disease	1.11e-05	0.00013	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCL2—Alzheimer's disease	1.11e-05	0.00013	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CRH—Alzheimer's disease	1.1e-05	0.000129	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCR5—Alzheimer's disease	1.09e-05	0.000127	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.09e-05	0.000127	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NPS—Alzheimer's disease	1.07e-05	0.000125	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.06e-05	0.000124	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.06e-05	0.000124	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TGFB1—Alzheimer's disease	1.06e-05	0.000124	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PTGS2—Alzheimer's disease	1.05e-05	0.000123	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—S100B—Alzheimer's disease	1.05e-05	0.000123	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—F2—Alzheimer's disease	1.05e-05	0.000123	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PTK2B—Alzheimer's disease	1.05e-05	0.000122	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NPS—Alzheimer's disease	1.04e-05	0.000122	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.04e-05	0.000121	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—F2—Alzheimer's disease	1.03e-05	0.00012	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.02e-05	0.00012	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.02e-05	0.00012	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PTK2B—Alzheimer's disease	1.02e-05	0.00012	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SST—Alzheimer's disease	1.02e-05	0.000119	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GAB2—Alzheimer's disease	1.02e-05	0.000119	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NTRK2—Alzheimer's disease	1.02e-05	0.000119	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CALM1—Alzheimer's disease	1.01e-05	0.000119	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GSK3A—Alzheimer's disease	1.01e-05	0.000118	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IGF2—Alzheimer's disease	1e-05	0.000117	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NTRK2—Alzheimer's disease	9.96e-06	0.000116	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SST—Alzheimer's disease	9.96e-06	0.000116	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GAB2—Alzheimer's disease	9.96e-06	0.000116	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CALM1—Alzheimer's disease	9.92e-06	0.000116	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APP—Alzheimer's disease	9.92e-06	0.000116	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GSK3A—Alzheimer's disease	9.88e-06	0.000115	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MAOB—Alzheimer's disease	9.82e-06	0.000115	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APP—Alzheimer's disease	9.71e-06	0.000114	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IGF1R—Alzheimer's disease	9.71e-06	0.000113	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—F2—Alzheimer's disease	9.53e-06	0.000111	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	9.46e-06	0.000111	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PLCB1—Alzheimer's disease	9.36e-06	0.000109	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	9.32e-06	0.000109	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—LPL—Alzheimer's disease	9.3e-06	0.000109	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MEF2C—Alzheimer's disease	9.22e-06	0.000108	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	9.16e-06	0.000107	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—A2M—Alzheimer's disease	9.13e-06	0.000107	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PRKCG—Alzheimer's disease	9.05e-06	0.000106	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NGF—Alzheimer's disease	8.81e-06	0.000103	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NGFR—Alzheimer's disease	8.73e-06	0.000102	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TP53—Alzheimer's disease	8.71e-06	0.000102	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CREB1—Alzheimer's disease	8.68e-06	0.000101	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCR5—Alzheimer's disease	8.57e-06	0.0001	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	8.55e-06	9.99e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADAM10—Alzheimer's disease	8.53e-06	9.97e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	8.49e-06	9.93e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCL2—Alzheimer's disease	8.49e-06	9.93e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR2A—Alzheimer's disease	8.39e-06	9.81e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	8.35e-06	9.76e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	8.31e-06	9.72e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—S100B—Alzheimer's disease	8.07e-06	9.43e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL6—Alzheimer's disease	7.97e-06	9.32e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ACHE—Alzheimer's disease	7.94e-06	9.29e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	7.9e-06	9.23e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	7.85e-06	9.18e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CALM1—Alzheimer's disease	7.83e-06	9.15e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—APOE—Alzheimer's disease	7.8e-06	9.12e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—LEP—Alzheimer's disease	7.8e-06	9.12e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CAV1—Alzheimer's disease	7.73e-06	9.03e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IGF2—Alzheimer's disease	7.68e-06	8.98e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	7.52e-06	8.79e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ESR1—Alzheimer's disease	7.45e-06	8.71e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	7.44e-06	8.7e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ENO1—Alzheimer's disease	7.44e-06	8.7e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IGF1R—Alzheimer's disease	7.43e-06	8.68e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—AKT1—Alzheimer's disease	7.36e-06	8.6e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—F2—Alzheimer's disease	7.36e-06	8.6e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	7.27e-06	8.5e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NOTCH1—Alzheimer's disease	7.2e-06	8.41e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—LPL—Alzheimer's disease	7.12e-06	8.32e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MEF2C—Alzheimer's disease	7.06e-06	8.25e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	6.97e-06	8.15e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PRKCG—Alzheimer's disease	6.92e-06	8.09e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—BCHE—Alzheimer's disease	6.92e-06	8.09e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	6.91e-06	8.07e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	6.78e-06	7.92e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GSK3B—Alzheimer's disease	6.75e-06	7.9e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NGF—Alzheimer's disease	6.74e-06	7.88e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CREB1—Alzheimer's disease	6.7e-06	7.83e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—INS—Alzheimer's disease	6.66e-06	7.79e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	6.6e-06	7.72e-05	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—AKT1—Alzheimer's disease	6.58e-06	7.69e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCR5—Alzheimer's disease	6.56e-06	7.67e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCL2—Alzheimer's disease	6.56e-06	7.66e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.53e-06	7.63e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IGF1—Alzheimer's disease	6.44e-06	7.53e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	6.42e-06	7.51e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	6.42e-06	7.51e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	6.33e-06	7.4e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	6.28e-06	7.35e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	5.99e-06	7e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—LEP—Alzheimer's disease	5.97e-06	6.98e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APOE—Alzheimer's disease	5.97e-06	6.98e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	5.91e-06	6.91e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	5.86e-06	6.85e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NOS3—Alzheimer's disease	5.84e-06	6.83e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	5.84e-06	6.83e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	5.84e-06	6.83e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	5.79e-06	6.77e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	5.7e-06	6.66e-05	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—AKT1—Alzheimer's disease	5.67e-06	6.63e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—F2—Alzheimer's disease	5.63e-06	6.58e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	5.58e-06	6.52e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—F2—Alzheimer's disease	5.51e-06	6.44e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	5.51e-06	6.44e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.46e-06	6.38e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.43e-06	6.35e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	5.39e-06	6.3e-05	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—AKT1—Alzheimer's disease	5.3e-06	6.2e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	5.17e-06	6.04e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	5.13e-06	5.99e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—INS—Alzheimer's disease	5.1e-06	5.96e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	5.06e-06	5.91e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	5.02e-06	5.87e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	5.02e-06	5.86e-05	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—AKT1—Alzheimer's disease	5.01e-06	5.85e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—INS—Alzheimer's disease	4.99e-06	5.83e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.97e-06	5.81e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CASP3—Alzheimer's disease	4.96e-06	5.8e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	4.93e-06	5.77e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL6—Alzheimer's disease	4.93e-06	5.76e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	4.91e-06	5.74e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	4.83e-06	5.64e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	4.56e-06	5.33e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	4.55e-06	5.32e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.47e-06	5.23e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	4.47e-06	5.23e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	4.38e-06	5.12e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	4.21e-06	4.92e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.18e-06	4.88e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.16e-06	4.87e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.13e-06	4.82e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	3.86e-06	4.52e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.83e-06	4.48e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	3.8e-06	4.44e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	3.77e-06	4.41e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.75e-06	4.38e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	3.72e-06	4.34e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	3.69e-06	4.31e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.63e-06	4.24e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—INS—Alzheimer's disease	3.56e-06	4.16e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	3.49e-06	4.08e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	3.48e-06	4.07e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	3.41e-06	3.99e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	3.41e-06	3.98e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	3.22e-06	3.77e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TP53—Alzheimer's disease	3.18e-06	3.72e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	3.15e-06	3.69e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.12e-06	3.65e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	2.96e-06	3.46e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6—Alzheimer's disease	2.91e-06	3.4e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	2.89e-06	3.38e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.85e-06	3.34e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	2.69e-06	3.14e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TP53—Alzheimer's disease	2.43e-06	2.85e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	2.38e-06	2.78e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6—Alzheimer's disease	2.23e-06	2.6e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	2.18e-06	2.55e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	2.06e-06	2.4e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	2.01e-06	2.35e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.43e-06	1.68e-05	CbGpPWpGaD
